We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Managing Infections, Cytopenias, and Other AEs Related to Bispecific Antibodies
Sagar Lonial, MD, FACP
Caitlin Costello, MD
Considerations for Dosing Bispecific Antibodies
Step-Up Dosing of Bispecific Antibodies: The Need for Hospitalization
Integrating Bispecific Antibodies Into Clinical Practice
Optimizing ICH Care By Leveraging AC Reversal, AI & Care Bundling
W. Brian Gibler, MD, FACEP, FACC, FAHA
Greg Albers, MD
Rhonda Cadena, MD, FNCS, FCCM
Stuart Connolly, MD, FRCPC
Natalie Kreitzer, MD, MS
Adrian R. Parry-Jones, FRCP, PhD
Providing Optimal Care for the Anticoagulated Patient with Intracranial Hemorrhage in the Acute Care Setting: Does the Patient Need Reversal, Repletion, or Surgery?
Implementation of the 2022 AHA/ASA Guideline for the Management of Patients with Spontaneous Intracerebral Hemorrhage—Are You Doing Enough?
ABC-ICH: Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?
Emerging Data in the Management of Intracranial Hemorrhage in the Anticoagulated Patient
The Frontier of Stroke Diagnosis (RapidAI): How Can Artificial Intelligence Improve Acute Care for Ischemic and Hemorrhagic Stroke?
Expanding Screening, Improving Treatment Acceptance, and Optimizing Outcomes for Patients with Moderate to Severe Alcohol Use Disorder (AUD)
Annie Levesque, MD, MSc
Ethan A. Cowan, MD
New Frontiers in Anticoagulation: Factor XI/XIa Inhibitors
Christopher B. Granger, MD
Manesh R. Patel, MD
M. Cecilia Bahit, MD
Elaine Hylek, MD, MPH
The DOAC Revolution: What Have We Learned?
While the DOAC Revolution Has Occurred, 40-50% of Patients Remain Untreated... Why?
While DOACs are Good for Some Things, They Are Not for Everyone
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education